CN1259873A - 以枯草芽孢杆菌活培养物为基的生物药制剂,治疗细菌、病毒感染和免疫缺陷症的方法 - Google Patents

以枯草芽孢杆菌活培养物为基的生物药制剂,治疗细菌、病毒感染和免疫缺陷症的方法 Download PDF

Info

Publication number
CN1259873A
CN1259873A CN98804473A CN98804473A CN1259873A CN 1259873 A CN1259873 A CN 1259873A CN 98804473 A CN98804473 A CN 98804473A CN 98804473 A CN98804473 A CN 98804473A CN 1259873 A CN1259873 A CN 1259873A
Authority
CN
China
Prior art keywords
preparation
infection
interferon
bacillus
bacillus subtilis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN98804473A
Other languages
English (en)
Chinese (zh)
Inventor
V·G·科斯特洛维斯奇
V·I·斯尔奇恩科
A·V·瓦伦德
S·N·格尼多伊
V·V·普斯多瓦伊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SYTO GENE CO Ltd
Original Assignee
SYTO GENE CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SYTO GENE CO Ltd filed Critical SYTO GENE CO Ltd
Publication of CN1259873A publication Critical patent/CN1259873A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/07—Bacillus
    • C12R2001/10—Bacillus licheniformis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CN98804473A 1998-05-12 1998-07-06 以枯草芽孢杆菌活培养物为基的生物药制剂,治疗细菌、病毒感染和免疫缺陷症的方法 Pending CN1259873A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU98108318/14A RU2156134C2 (ru) 1998-05-12 1998-05-12 Биофармацевтический препарат на основе живой культуры bacillus и способ лечения заболевания инфекционной природы
RU98108318 1998-05-12

Publications (1)

Publication Number Publication Date
CN1259873A true CN1259873A (zh) 2000-07-12

Family

ID=20205503

Family Applications (1)

Application Number Title Priority Date Filing Date
CN98804473A Pending CN1259873A (zh) 1998-05-12 1998-07-06 以枯草芽孢杆菌活培养物为基的生物药制剂,治疗细菌、病毒感染和免疫缺陷症的方法

Country Status (6)

Country Link
JP (1) JP2002521002A (fr)
CN (1) CN1259873A (fr)
AU (1) AU8892198A (fr)
CA (1) CA2288993A1 (fr)
RU (1) RU2156134C2 (fr)
WO (1) WO1999058137A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1511512A1 (fr) * 2002-05-29 2005-03-09 Bayer HealthCare AG Nouvelles utilisations de preparations de parapoxvirus

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1156317B (it) * 1982-09-08 1987-02-04 Anic Spa Vettori plasmidici ad espressione in bacillus subtilis e procedimento per la loro preparazione
GB8805394D0 (en) * 1988-03-07 1988-04-07 Agricultural Genetics Co Antibiotic
SU1648975A1 (ru) * 1988-04-15 1991-05-15 Оренбургский Государственный Медицинский Институт Штамм бактерий BacILLUS SUвтILIS, используемый дл получени молочного продукта, предназначенного дл лечени диатеза, дисбактериоза и бактериальных инфекций
GB9226729D0 (en) * 1992-12-22 1993-02-17 Wellcome Found Therapeutic combination
RU2084233C1 (ru) * 1994-07-15 1997-07-20 Научно-исследовательский институт сельского хозяйства Северо-Востока им.Н.В.Рудницкого Способ получения пробиотика для ветеринарии

Also Published As

Publication number Publication date
AU8892198A (en) 1999-11-29
CA2288993A1 (fr) 1999-11-18
WO1999058137A1 (fr) 1999-11-18
JP2002521002A (ja) 2002-07-09
RU2156134C2 (ru) 2000-09-20

Similar Documents

Publication Publication Date Title
EP0568200A2 (fr) Compositions pharmaceutiques et alimentaires contenant des transferrines et des agents antibactériens pour améliorer l'activité des dépenses immunitaires et pour le traitement d'infections
CN105535964A (zh) 一种具有免疫调节作用的双链聚核苷酸—ε-聚赖氨酸—硫酸聚糖复合物及其制备使用方法
JP3224131B2 (ja) 菌、卵白及びにんにくの２種以上を含有する免疫賦活・感染防御剤
CN1108104A (zh) 药用莫诺霉素及其衍生物、含莫诺霉素或其衍生物的药剂
CN1259873A (zh) 以枯草芽孢杆菌活培养物为基的生物药制剂,治疗细菌、病毒感染和免疫缺陷症的方法
EP0213692B1 (fr) Utilisation de l'hygromycine et de l'épihygromycine pour le traitement de la dysenterie du porc
CN113117048A (zh) 抗多发性硬化症药Fty720与多粘菌素系统在抗肺炎克雷伯杆菌中的应用
CN1105563A (zh) 抗菌组合物
CN1204881C (zh) 烯丙胺衍生物在制备治疗幽门螺杆菌感染和相关疾病的药物方面的用途
EP0431933B1 (fr) Médicaments formulés pour augmenter l'efficacité d'antibiotiques de bêtalactame en prophylaxie et traitement de maladie infectieuse par suite de bactéries pathogènes
EP0299794B1 (fr) Composés de la lactone de l'acide résorcylique pour la lutte contre les parasites helmintiques
EP0238207B1 (fr) Mélanges bactéricides
CN1159760A (zh) 用于阴道感染的肠内疫苗
CN1082795C (zh) 甲壳动物的饲料和饲料添加剂
RU2663324C1 (ru) Способ лечения кроликов при миксоматозе
CN1203819A (zh) 肠出血性大肠杆菌感染的预防和治疗
US6328989B1 (en) Use of bicozamycin for the manufacture of a medicament for treating infections with enterohemorrhagic e. coli
UA80502C2 (en) Pharmaceutical anti-herpetic composition, method for dosage form production and method for its application
CN1232302C (zh) 一种阿齐霉素与匹多莫德复方制剂
SU1681858A1 (ru) Способ повышени резистентности порос т к инфекционным заболевани м
RU2185840C1 (ru) Лекарственный препарат для профилактики и лечения инфекционных заболеваний
US2558702A (en) Sulfonamides preparation
CN1377274A (zh) 用母牛分枝杆菌治疗慢性病毒感染
JPS62149616A (ja) 感染防御能増強剤
Vebmeulen et al. Experimental Urolithiasis VIII: Furadantin in Treatment of Experimental Proteus Infection with Stone Formation

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication